Compare Accretion Nutrav with Similar Stocks
Total Returns (Price + Dividend) 
Accretion Nutrav for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
Announcements 
Announcement under Regulation 30 (LODR)-Press Release / Media Release
15-May-2026 | Source : BSEAccretion Nutraveda Limited has informed the Exchange regarding Press Release dated 15th May 2026 titled Company Delivers Robust Performance in H2 FY26 : Revenue up 80.09% YOY and EBITDA up 42.64% and growth Driven by strong demand Operational Expansion and Expanding Market Presence.
Announcement under Regulation 30 (LODR)-Resignation of Director
08-May-2026 | Source : BSEPlease find enclosed herewith resignation of Mr. Mahipal singh chouhan as non-Executive Independent Director of the Company.
Appointment Of Internal Auditors
08-May-2026 | Source : BSEPlease find enclosed herewith Intimation with respect to Appointment Internal Auditor of the company.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (1.08%)
Ankurkumar Shantilal Patel (14.7%)
Unicorn Fund (6.59%)
14.19%
Half Yearly Results Snapshot (Standalone) - Mar'26
Growth in half year ended Mar 2026 is 38.98% vs 29.59% in Sep 2025
Growth in half year ended Mar 2026 is 15.45% vs 35.47% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 110.00% vs 219.36% in Mar 2025
YoY Growth in year ended Mar 2026 is 102.80% vs 204.88% in Mar 2025






